Jalota Deepika
Chief Development Officer at PMVP
- Sold, on record
- $171k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jul 1, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PMVPPMV Pharmaceuticals, Inc.Chief Development Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PMVPUnusualAug 17, 2021 2021
Sold 2,896 shares at $33.78 ($98k)
Jalota Deepika, SVP, Regulatory Affairs and QA
Sold 100% of holdings ($98k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale PMVPNo planSep 15, 2023 +759 days
Sold 4,104 shares at $6.62 ($27k)
Jalota Deepika, Chief Development Officer
No 10b5-1 planSold 12.1% of holdings ($225k position)29,946 shares leftFirst sale on recordFiling
- 3 Form 4 sale PMVPNo planSep 11, 2024 +362 days
Sold 7,218 shares at $1.50 ($11k)
Jalota Deepika, Chief Development Officer
No 10b5-1 planSold 5.8% of holdings ($188k position)118,283 shares leftFiling
- 4 Form 4 sale PMVPUnusualJul 1, 2025 +293 days
Sold 33,065 shares at $1.06 ($35k)
Jalota Deepika, Chief Development Officer
No 10b5-1 planSold 26.9% of holdings ($130k position)89,959 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Jul 3, 2025 | PMVP | Chief Development Officer | Form 4 sale | 33,065 | $35k | 26.9% | Unusual | SEC |
| Sep 11, 2024 | Sep 12, 2024 | PMVP | Chief Development Officer | Form 4 sale | 7,218 | $11k | 5.8% | No plan | SEC |
| Sep 15, 2023 | Sep 18, 2023 | PMVP | Chief Development Officer | Form 4 sale | 4,104 | $27k | 12.1% | No plan | SEC |
| Aug 17, 2021 | Aug 18, 2021 | PMVP | SVP, Regulatory Affairs and QA | Form 4 sale | 2,896 | $98k | 100.0% | Unusual | SEC |